Breaks Categories: News

ThursdayMay 14, 2026 11:35 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on CNS Drug Delivery Innovation 

Oncotelic Therapeutics (OTCQB: OTLC) announced its featured placement in a BioMedWire editorial focused on emerging CNS drug delivery technologies addressing challenges in Alzheimer’s disease and biodefense research. The editorial highlights the company’s proprietary intranasal nose-to-brain delivery platform, designed to bypass the blood-brain barrier and enable direct therapeutic delivery to the central nervous system, reflecting growing interest in advanced drug delivery approaches for neurological treatment. To view the full press release, visit https://nnw.fm/QuqMV About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy products. The Company’s mission is to address high-unmet-need cancers and rare pediatric indications with innovative, late-stage…

Continue Reading

ThursdayMay 14, 2026 11:27 am

NetworkNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Emerging GLP-1 Innovation  

This article has been disseminated on behalf of SureNano Science Ltd.  and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its featured placement in a BioMedWire editorial examining next-generation innovation in the rapidly expanding GLP-1 therapeutic market. The editorial highlights the company’s subsidiary GlucaPharm Inc. and its development of GEP-44, a novel triple agonist peptide designed to enhance efficacy, tolerability and delivery flexibility in the treatment of obesity, type 2 diabetes and related metabolic conditions. To view the full press release, visit https://nnw.fm/dx79V About SureNano Science Ltd. SureNano Science Ltd. (CSE: SURE) is a Canadian life sciences company focused on acquiring, developing, and advancing innovative pharmaceutical and biotechnology assets with the potential to address large and growing…

Continue Reading

ThursdayMay 14, 2026 11:14 am

NetworkNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Shareholders Approve All Proposals at Annual Meeting 

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) announced that shareholders approved all proposals at its annual meeting held May 13, 2026, with 108.4 million shares, representing 62.84% of eligible outstanding shares, represented at the meeting. Shareholders elected all nominated directors, approved the appointment of auditors, and passed the company’s non-binding advisory vote on executive compensation. To view the full press release, visit https://nnw.fm/CWa3E About Trilogy Metals Trilogy Metals Inc. is a metal exploration and development company holding a 50 percent interest in Ambler Metals LLC, which has a 100 percent interest in the Upper Kobuk…

Continue Reading

ThursdayMay 14, 2026 10:10 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Autonomous Warfare Technologies

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced its featured placement in an editorial published by AINewsWire examining the evolving role of autonomous software in modern warfare. The editorial highlights SPARC AI’s software-only platform designed to provide drones with GPS-denied navigation and precision targeting capabilities, addressing growing defense demand for autonomous intelligence systems that can operate effectively in contested electronic warfare environments. To view the full press release, visit https://nnw.fm/keot1 About SPARC AI Inc. SPARC AI is a defence technology company solving one…

Continue Reading

ThursdayMay 14, 2026 10:00 am

NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on Real-Time Intoxication Detection Technologies

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced its featured placement in an editorial published by BioMedWire, highlighting emerging opportunities in real-time intoxication detection technologies. The editorial spotlights MindBio’s AI-driven voice analysis platform, which is being developed to detect impairment from brief speech recordings across a range of substances, addressing growing demand for faster, noninvasive and scalable intoxication detection solutions across healthcare, workplace safety and public health applications. To view the full press release, visit https://nnw.fm/1WCqA About MindBio Therapeutics Corp. MindBio is a…

Continue Reading

ThursdayMay 14, 2026 9:50 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports First-Quarter 2026 Results, Advances Strategic Transformation

CNS Pharmaceuticals (NASDAQ: CNSP) reported first-quarter 2026 financial results while outlining progress in its strategic transformation toward an acquisition-driven growth model focused on clinical-stage neurology and oncology assets. Following quarter end, the company strengthened its balance sheet with a $22.5 million private placement, which, together with existing cash, is expected to support operations beyond 12 months as CNS pursues asset acquisitions and explores out-licensing opportunities for its legacy glioblastoma programs. To view the full press release, visit https://nnw.fm/HP5Xy About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a biotechnology company focused on developing innovative therapies for serious diseases. With an experienced executive…

Continue Reading

ThursdayMay 14, 2026 9:36 am

NetworkNewsBreaks – BOXABL, FG Merger II Advance Proposed Business Combination Following SEC Effectiveness of Form S-4 

BOXABL and FG Merger II Corp. (NASDAQ: FGMC) announced that the U.S. Securities and Exchange Commission has declared effective the companies’ joint registration statement on Form S-4 related to their proposed business combination, marking a significant milestone in BOXABL’s path to becoming a publicly traded company. Shareholder meetings to approve the transaction are scheduled for June 9, 2026, with closing expected shortly thereafter, subject to customary conditions, after which the combined company is expected to trade on Nasdaq under the ticker symbol BXBL. To view the full press release, visit https://nnw.fm/vSixg About BOXABL BOXABL is transforming the housing market with its modular building systems…

Continue Reading

ThursdayMay 14, 2026 9:10 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart attack detection and ambulatory ECG patch initiatives, and an April public offering that raised $11.5 million in gross proceeds. The company reported a first-quarter net loss of $4.7 million, improved from $5.5 million in the prior-year period, with research and development expenses declining year over year as HeartBeam continued advancing commercialization of its FDA-cleared cardiac monitoring platform and related growth initiatives. To view the full press release, visit https://nnw.fm/guMCF About HeartBeam, Inc. HeartBeam,…

Continue Reading

ThursdayMay 14, 2026 9:00 am

NetworkNewsBreaks – Nevada Organic Phosphate Inc. CSE: NOP; OTCQB: NOPFF) Announces Non-Brokered Private Placement of Up to $2 Million

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based leader in organic sedimentary phosphate exploration, announced plans to complete a non-brokered private placement of up to 11.1 million units at $0.18 per unit for gross proceeds of up to $2 million. Proceeds are expected to fund the phase two drill program at the company’s Murdock Property and general working capital. To view the full press release, visit https://nnw.fm/bueMz Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) NOP is a junior exploration company with…

Continue Reading

WednesdayMay 13, 2026 11:55 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Permanent Ukraine Operations to Accelerate Overwatch Adoption

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced plans to establish permanent operations in Ukraine through a wholly owned subsidiary to accelerate adoption of its Overwatch autonomous mission software across the country’s defense drone market. The expansion includes building an in-country commercial and technical team, opening a physical office, and appointing Greg Daly as chief strategy and mission integration officer to lead execution, as the company works to convert growing engagement with Ukrainian drone manufacturers and operators into recurring software sales while expanding…

Continue Reading